We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

One-Step Test Developed for Hepatitis C Virus Infection

By LabMedica International staff writers
Posted on 30 Nov 2015
Print article
Image: Histopathology of a liver chronically infected with Hepatitis C virus; necrosis and inflammation are prominent, and there is some steatosis as well (Photo courtesy of the University of Utah).
Image: Histopathology of a liver chronically infected with Hepatitis C virus; necrosis and inflammation are prominent, and there is some steatosis as well (Photo courtesy of the University of Utah).
A cost-effective one-step test that screens, detects, and confirms Hepatitis C virus (HCV) infections has been developed as an alternative to current blood-based HCV testing that requires two steps and can be expensive, inconvenient, and not widely available or affordable globally.

Although the current HCV screening test is specific and sensitive, it cannot distinguish active infection from a previous infection, and virus-specific antibodies must be detected in the blood and then the sensitive HCV ribonucleic acid polymerase chain reaction (RNA PCR) test must be administered to confirm whether or not the infection is active.

Scientists at the University of California Irvine (CA, USA) developed the new test that samples urine instead of blood, and there is potential to significantly reduce the human resources, time, and cost involved with testing. The HCV RNA PCR test in the USA costs more than USD 200. The new assay is a highly specific and sensitive HCV antigens enzyme immunoassay (HCV-AGS EIA) for one-step diagnosis of viremic HCV infection.

According to the Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA), approximately 150 million people worldwide and 3.2 million people in the USA are infected with HCV. Effective screening and fast diagnosis are critical for treatment and controlling transmission. People with an HCV infection do not usually experience symptoms until more serious liver injury develops, such as fibrosis, cirrhosis, or liver cancer. The CDC recommends screening tests for high-risk patients, including intravenous drug users, and individuals who had blood transfusions before 1992, as well as those born between 1945 and 1965.

Dr. Ke-Qin Hu, MD, director of hepatology services and lead author of the study, said, “Our novel HCV antigen test system has significantly improved sensitivity and specificity over current tests. Importantly, for the first time, we can use urine specimens for one-step screening and diagnosing of HCV infection. Finding a more convenient, easy-to-use and cost-effective screening alternative is imperative, because HCV is significantly under-screened and under-diagnosed. The ability to detect infection using urine rather than blood avoids needle stick and blood sample collection, greatly reduces the cost and necessary clinical infrastructure for screening and diagnosis, helping to promote widespread adoption of the test on a global scale.” The study was presented at the Annual Meeting of American Association for the Study of Liver Disease (AASLD) held November, 14–16, 2015, in San Francisco (CA, USA).

Related Links:

University of California Irvine 
US Centers for Disease Control and Prevention 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.